NM_015226.3:c.80+3540A>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_015226.3(CLEC16A):c.80+3540A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 152,236 control chromosomes in the GnomAD database, including 1,992 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.14 ( 1992 hom., cov: 33)
Consequence
CLEC16A
NM_015226.3 intron
NM_015226.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0480
Publications
20 publications found
Genes affected
CLEC16A (HGNC:29013): (C-type lectin domain containing 16A) This gene encodes a member of the C-type lectin domain containing family. Single nucleotide polymorphisms in introns of this gene have been associated with diabetes mellitus, multiple sclerosis and rheumatoid arthritis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
CLEC16A Gene-Disease associations (from GenCC):
- schizophreniaInheritance: Unknown Classification: NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.212 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CLEC16A | ENST00000409790.6 | c.80+3540A>G | intron_variant | Intron 1 of 23 | 5 | NM_015226.3 | ENSP00000387122.1 | |||
| CLEC16A | ENST00000409552.4 | c.80+3540A>G | intron_variant | Intron 1 of 20 | 1 | ENSP00000386495.3 | ||||
| CLEC16A | ENST00000703130.1 | c.80+3540A>G | intron_variant | Intron 1 of 22 | ENSP00000515187.1 |
Frequencies
GnomAD3 genomes AF: 0.145 AC: 22048AN: 152116Hom.: 1991 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
22048
AN:
152116
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.145 AC: 22046AN: 152236Hom.: 1992 Cov.: 33 AF XY: 0.144 AC XY: 10713AN XY: 74442 show subpopulations
GnomAD4 genome
AF:
AC:
22046
AN:
152236
Hom.:
Cov.:
33
AF XY:
AC XY:
10713
AN XY:
74442
show subpopulations
African (AFR)
AF:
AC:
2030
AN:
41570
American (AMR)
AF:
AC:
2219
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
AC:
1060
AN:
3472
East Asian (EAS)
AF:
AC:
567
AN:
5190
South Asian (SAS)
AF:
AC:
1078
AN:
4832
European-Finnish (FIN)
AF:
AC:
1645
AN:
10576
Middle Eastern (MID)
AF:
AC:
60
AN:
294
European-Non Finnish (NFE)
AF:
AC:
12818
AN:
67984
Other (OTH)
AF:
AC:
384
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
946
1892
2838
3784
4730
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
641
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.